JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia

BACKGROUND: The JAK2 V617F mutation has been noted in the cases of polycythemia vera, essential thrombocythemia, and primary myelofibrosis patients. This mutation occurs less frequently in acute myeloid leukemia (AML) and other hematologic diseases, such as myelodysplastic syndrome (MDS); myelodyspl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jekarl, Dong Wook, Han, Sang Bong, Kim, Myungshin, Lim, Jihyang, Oh, Eun-Jee, Kim, Yonggoo, Kim, Hee-Je, Min, Woo-Sung, Han, Kyungja
Format: Artigo
Sprache:Inglês
Veröffentlicht: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2010
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2983014/
https://ncbi.nlm.nih.gov/pubmed/21120162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/kjh.2010.45.1.46
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge